Allison R. Eberly
Impact in
- Endocrinology top 5%
- Escherichia coli research studies
- Vibrio bacteria research studies
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria
Papers in
-
- Escherichia coli research studies 7
-
- Antibiotic Resistance in Bacteria 6
- Co-authors
- Maria Hadjifrangiskou (10 shared papers)Erin J. Breland (2 shared papers)Connor J. Beebout (4 shared papers)Kyle A. Floyd (3 shared papers)Charles W. Stratton (2 shared papers)Jonathan E. Schmitz (3 shared papers)Eric Patrick Skaar (1 shared paper)Richard M. Caprioli (1 shared paper)
- Journals
- Journal of Clinical Microbiology (2 papers)mBio (1 paper)Biofilm (1 paper)npj Biofilms and Microbiomes (1 paper)International Journal of Molecular Sciences (1 paper)
- Partner nations
- United StatesGermanySweden
In The Last Decade
Allison R. Eberly
22 papers receiving 395 citations
Peers
Comparison fields: 5 of 67
- Endocrinology 160
- Molecular Medicine 81
- Clinical Biochemistry 33
- Epidemiology 114
- Microbiology 21
Countries citing papers authored by Allison R. Eberly
This map shows the geographic impact of Allison R. Eberly's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Allison R. Eberly with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Allison R. Eberly more than expected).
Fields of papers citing papers by Allison R. Eberly
This network shows the impact of papers produced by Allison R. Eberly. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Allison R. Eberly. The network helps show where Allison R. Eberly may publish in the future.
Co-authors
The 25 scholars most cited alongside Allison R. Eberly, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 75 | |
| 2 | 2019 | 71 | |
| 3 | 2017 | 60 | |
| 4 | 2017 | 48 | |
| 5 | 2017 | 34 | |
| 6 | 2021 | 24 | |
| 7 | 2016 | 22 | |
| 8 | 2019 | 20 | |
| 9 | 2018 | 14 | |
| 10 | 2022 | 6 | |
| 11 | 2022 | 6 | |
| 12 | 2021 | 5 | |
| 13 | 2022 | 4 | |
| 14 | 2023 | 3 | |
| 15 | 2024 | 2 | |
| 16 | 2022 | 2 | |
| 17 | 2024 | 2 | |
| 18 | 2023 | 1 | |
| 19 | 2025 | 1 | |
| 20 | 2021 | 1 |
About Allison R. Eberly
Allison R. Eberly is a scholar working on Endocrinology, Molecular Medicine, Clinical Biochemistry, Epidemiology and Infectious Diseases, having authored 23 papers that have together received 403 indexed citations. Recurring topics across this work include Escherichia coli research studies (7 papers), Bacterial Identification and Susceptibility Testing (6 papers), Antibiotic Resistance in Bacteria (6 papers), Urinary Tract Infections Management (5 papers), Bacterial Genetics and Biotechnology (4 papers), Gut microbiota and health (4 papers), Streptococcal Infections and Treatments (3 papers) and Infective Endocarditis Diagnosis and Management (2 papers). The work is most often cited by research in Endocrinology (160 citations), Molecular Medicine (81 citations), Clinical Biochemistry (33 citations), Epidemiology (114 citations) and Microbiology (21 citations). Allison R. Eberly has collaborated with scholars based in United States, Germany and Sweden. Frequent co-authors include Maria Hadjifrangiskou, Erin J. Breland, Connor J. Beebout, Kyle A. Floyd, Charles W. Stratton, Jonathan E. Schmitz, Eric Patrick Skaar, Richard M. Caprioli, Douglass B. Clayton and Carrie L. Shaffer. Their work appears in journals such as Journal of Clinical Microbiology, mBio, Biofilm, npj Biofilms and Microbiomes and International Journal of Molecular Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.